Curi RMB Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Curi RMB Capital’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-13,178	Closed	-$789K	–	700
2019 Q3	$789K	Sell	13,178 -7,708	-37%	-$502K	0.02%	424
2019 Q2	$1.34M	Sell	20,886 -10,142	-33%	-$717K	0.03%	377
2019 Q1	$2.52M	Hold	31,028	–	–	0.06%	298
2018 Q4	$1.68M	Sell	31,028 -5,007	-14%	-$255K	0.04%	383
2018 Q3	$1.86M	Sell	36,035 -2,503	-6%	-$118K	0.04%	401
2018 Q2	$1.61M	Sell	38,538 -14,950	-28%	-$663K	0.04%	423
2018 Q1	$2.36M	Sell	53,488 -13,354	-20%	-$678K	0.06%	357
2017 Q4	$3.36M	Sell	66,842 -15,793	-19%	-$866K	0.09%	296
2017 Q3	$4.19M	Sell	82,635 -470	-0.6%	-$24.6K	0.11%	267
2017 Q2	$4.23M	Buy	+83,105	New	+$3.87M	0.12%	248

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Curi RMB Capital's IONS Position: Q4 2019 in Review

Curi RMB Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2019, closing a stake of 13,178 shares — an estimated $789K sold.

Curi RMB Capital first reported a position in IONS in Q2 2017 and held it in 10 quarters. The position peaked at $4.23M in Q2 2017. 390 funds tracked by Wall St. Rank hold IONS as of Q4 2019.

Curi RMB Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Curi RMB Capital sold 13,178 Ionis Pharmaceuticals shares in Q4 2019, an estimated $789K.
Curi RMB Capital first reported a position in Ionis Pharmaceuticals in Q2 2017 and held it in 10 quarters.
Curi RMB Capital's Ionis Pharmaceuticals position peaked at $4.23M in Q2 2017.
390 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2019.

Based on Curi RMB Capital's 13F filing for Q4 2019, filed 13 Feb 2020.